Literature DB >> 7862719

Preference for high- versus low-potency marijuana.

L D Chait1, K A Burke.   

Abstract

With many drugs of abuse, humans and other species display a preference for higher doses (or more potent dosage forms) over lower doses (or less potent dosage forms). The present study was designed to determine whether this generalization would hold for marijuana smoking by humans. Twelve regular marijuana smokers participated in two independent and identical choice trials in which, on separate sessions, they first sampled marijuana of two different potencies (0.63% and 1.95% delta-9-tetrahydrocannabinol; THC) and then, on the next session, chose which of the two, as well as how much, to smoke. During sampling sessions, the high-potency marijuana produced a greater heart rate increase and greater subjective effects than the low-potency marijuana. Subjects chose the high-potency marijuana significantly more often than the low-potency marijuana (21 out of 24 choice occasions). These results support the hypothesis that the reinforcing effects of marijuana, and possibly its abuse liability, are positively related to THC content.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7862719     DOI: 10.1016/0091-3057(94)90082-5

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  9 in total

Review 1.  The marijuana withdrawal syndrome: diagnosis and treatment.

Authors:  Margaret Haney
Journal:  Curr Psychiatry Rep       Date:  2005-10       Impact factor: 5.285

2.  Reinforcing effects of oral Delta9-THC in male marijuana smokers in a laboratory choice procedure.

Authors:  Carl L Hart; Margaret Haney; Suzanne K Vosburg; Sandra D Comer; Richard W Foltin
Journal:  Psychopharmacology (Berl)       Date:  2005-04-14       Impact factor: 4.530

Review 3.  Self-administration of cannabinoids by experimental animals and human marijuana smokers.

Authors:  Zuzana Justinova; Steven R Goldberg; Stephen J Heishman; Gianluigi Tanda
Journal:  Pharmacol Biochem Behav       Date:  2005-06       Impact factor: 3.533

4.  Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigm.

Authors:  Margaret Rukstalis; Christopher Jepson; Andrew Strasser; Kevin G Lynch; Kenneth Perkins; Freda Patterson; Caryn Lerman
Journal:  Psychopharmacology (Berl)       Date:  2005-01-29       Impact factor: 4.530

5.  Smoked cannabis for chronic neuropathic pain: a randomized controlled trial.

Authors:  Mark A Ware; Tongtong Wang; Stan Shapiro; Ann Robinson; Thierry Ducruet; Thao Huynh; Ann Gamsa; Gary J Bennett; Jean-Paul Collet
Journal:  CMAJ       Date:  2010-08-30       Impact factor: 8.262

Review 6.  Self-administration of cocaine, cannabis and heroin in the human laboratory: benefits and pitfalls.

Authors:  Margaret Haney
Journal:  Addict Biol       Date:  2008-10-09       Impact factor: 4.280

7.  Acute effects of THC on time perception in frequent and infrequent cannabis users.

Authors:  R Andrew Sewell; Ashley Schnakenberg; Jacqueline Elander; Rajiv Radhakrishnan; Ashley Williams; Patrick D Skosnik; Brian Pittman; Mohini Ranganathan; D Cyril D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2012-11-24       Impact factor: 4.530

8.  Associations between self-reported cannabis use frequency, potency, and cannabis/health metrics.

Authors:  Christine M Steeger; Leah N Hitchcock; Angela D Bryan; Kent E Hutchison; Karl G Hill; L Cinnamon Bidwell
Journal:  Int J Drug Policy       Date:  2021-05-30

Review 9.  Characteristics that influence purchase choice for cannabis products: a systematic review.

Authors:  Jennifer Donnan; Omar Shogan; Lisa Bishop; Michelle Swab; Maisam Najafizada
Journal:  J Cannabis Res       Date:  2022-02-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.